Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Norway
/
Mark William-Semrau Gaffney
MW
Mark William-Semrau Gaffney
Chief Executive Officer, CALLUNA PHARMA AS
NO
3 active roles
Watchlist
Share
Overview
Companies & roles
Network
Loading profile…
Companies & roles
Active roles
3 positions
Company
Role
Period
Ownership
Status
CALLUNA PHARMA AS
CVR 932255189
Management
Chief Executive Officer
Since 2024
—
Active
ARXX THERAPEUTICS AS
CVR 815295242
Board
Board of Directors
Since 2025
—
Active
CALLUNA PHARMA US, INC.
CVR 935834139
Management
Chief Executive Officer
Since 2025
—
Active
More on Mark William-Semrau Gaffney
Overview →
Headline figures, risk signals and profile summary
Network →
Connections across other directors and entities
